SCHEMBL8287397

SCHEMBL8287397

Cc1cc(C(N)=O)nc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.46
POLB P06746 1/20 0.38
GRM2 Q14416 3/20 0.38
PDE4B Q07343 2/20 0.38
PDE4A P27815 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
GAA P10253 3/20 0.36
HPGD P15428 3/20 0.36
MAPK1 P28482 1/20 0.36
GFER P55789 1/20 0.36
PIM1 P11309 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
MAPT P10636 2/20 0.36
CSF1R P07333 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
GSK3B P49841 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5872175 0.91 PDE11A (0.47) PDE11APOLBGAAHPGDMAPK1
SCHEMBL5871541 0.90 PDE11A (0.46) PDE11APOLBGAAHPGDMAPK1
SCHEMBL8287393 0.89 PDE11A (0.46) PDE11APOLBHPGDMAPK1MAPT
SCHEMBL8285169 0.88 PDE11A (0.45) PDE11APOLBGAAHPGDMAPK1
SCHEMBL8287518 0.87 PDE11A (0.44) PDE11APOLBGAAHPGDMAPK1
SCHEMBL8285223 0.87 PDE11A (0.44) PDE11APOLBGAAHPGDMAPK1
SCHEMBL8285186 0.87 ADORA3 (0.37) PDE11APOLBGRM2GAAHPGD
SCHEMBL8286396 0.86 PDE11A (0.44) PDE11APOLBGAAHPGDMAPK1
SCHEMBL8286399 0.86 PDE11A (0.46) PDE11APOLBGAAHPGDMAPK1
SCHEMBL8285174 0.85 PDE11A (0.43) PDE11APOLBGAAHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed